Perioperative Immune Checkpoint Inhibitors Combined with Radical Cystectomy: A Rapid Systematic Review and Meta-analysis
We reviewed studies in patients with muscle-invasive bladder cancer who received immunotherapy around the time of surgery. The results suggest that combining immunotherapy with surgery may offer a benefit, but further research is needed to determine which patients benefit the most and the best timing and combinations of these treatments.
Authors
- Navid Roessler (ORCID: https://orcid.org/0009-0008-2792-9828)
- P. Rajwa
- Markus von Deimling (ORCID: https://orcid.org/0000-0002-9954-3413)
- Morgan Rouprêt
- Margit Fisch
- Shahrokh F. Shariat
- Shota Inoue
- Marcin Miszczyk
- Keiichiro Miyajima
- David D’Andrea
Institutions
- Al-Ahliyya Amman University (JO)
- Jikei University School of Medicine (JP)
- Universität Hamburg (DE)
- Okayama University (JP)
- Medical University of Silesia (PL)
- Cornell University (US)
- Charles University (CZ)
- Sorbonne Université (FR)
- Comprehensive Cancer Center Vienna (AT)
- Assistance Publique – Hôpitaux de Paris (FR)
- University Medical Center Hamburg-Eppendorf (DE)
- Pitié-Salpêtrière Hospital (FR)
- WSB University (PL)
- Karl Landsteiner Society (AT)
- Onco-Urologie Prédictive
- Medical University of Vienna (AT)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- European Urology Open Science
- Published
- 2026-02-11
- DOI
- https://doi.org/10.1016/j.euros.2026.01.016
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00